Biologics

Regenerative medicine in spine and orthopedics is gaining momentum, and many surgeons expect further development and research for the field in the near future.

Kuros Biosciences launched the MagnetOs Easypack Putty in the U.S.

Ortho Regenerative Technologies received a patent related to its Ortho-R soft tissue repair platform.

Xtant Medical named Scott Neils as CFO starting June 1.

A healthcare analytics company broke into the medtech market, acquiring Pur Biologics.

From approvals to acquisitions, here are eight developments in regenerative medicine to know since March 1.

The worldwide orthopedic regenerative surgical product market is expected to reach $5.6 billion by 2030, according to Research and Markets.

Kuros Biosciences' MagenetOs Flex Matrix was cleared by the FDA for use as a bone void filler in the posterolateral spine.

RTI Surgical, which develops biologic implants, is expanding its facility in Alachua, Fla., The Gainesville Sun reported April 18.

Bioventus has exercised its call option to acquire Israeli devicemaker CartiHeal for up to $450 million following the FDA's premarket approval of the Agili-C implant on March 29.